Although PPARγ ligands have been shown to inhibit TGFβ-stimulated profibrotic differentiation of lung fibroblasts in vitro and to reduce lung scarring in animal models of pulmonary fibrosis [102], the role of myofibroblast-derived PPARγ in cancer progression remains unknown. Here, PPARG is linked to pulmonary fibrosis.